Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Revenues:
Net product sales	$ 144,285	$ 127,044	$ 107,672
Cost of product sales	38,648	65,105	54,874
Gross profit	105,637	61,939	52,798
Operating expenses:
Research and development	16,683	39,133	82,704
General and administrative	53,397	65,778	62,239
Sales and marketing	47,085	67,643	82,513
Total operating expenses	117,165	172,554	227,456
Loss from operations	(11,528)	(110,615)	(174,658)
Other (expense) income, net:
Interest income	3,550	3,364	1,638
Interest expense	(6,032)	(3,868)	(2,474)
Other income (expense)	430	560	(6,530)
Total other (expense) income, net	(2,052)	56	(7,366)
Net loss	(13,580)	(110,559)	(182,024)
Other comprehensive income (loss):
Unrealized gains (losses) on short-term investments		32	(13)
Comprehensive loss	$ (13,580)	$ (110,527)	$ (182,037)
Basic net loss per share	$ (0.09)	$ (0.8)	$ (1.67)
Shares used in computing basic net loss per share	152,449	138,135	108,876
Diluted net loss per share	$ (0.09)	$ (0.8)	$ (1.67)
Shares used in computing diluted net loss per share	152,449	138,135	108,876